Abstract: The present invention relates to methods of generating a population of beta cells from a population of alpha cells, by contacting said population of alpha cells with GABA or a GABA receptor agonist, in combination with a monoclonal glucagon neutralizing antibody or other alpha cell mass regulating compounds, for an improved diabetes therapy.
Type:
Grant
Filed:
December 23, 2015
Date of Patent:
April 7, 2020
Assignees:
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE DE NICE SOPHIA ANTIPOLIS-GRAND CHÂTEAU
Inventors:
Jacob Hecksher-Sørensen, Patrick Collombat